Skip to main content
SpringerLink
Log in

Financial Toxicity

Finanzielle Belastungen bei Krebs

Financial toxicity

Financial burden due to cancer

  • Fokus
  • Published:
Forum Aims and scope

Zusammenfassung

Finanzielle Belastungen von Krebsüberlebenden sind, trotz universeller Krankenversicherung und eines ausgeprägten Sozialversicherungssystems, in Deutschland möglich. Objektive finanzielle Belastungen, wie Zuzahlungen und Einkommensverluste, führen zu subjektiver finanzieller Belastung bei KrebspatientInnen. Subjektive finanzielle Belastungen zeigen sich auf der materiellen, der psychosozialen und der Verhaltensebene. Leiden Überlebende unter subjektiver finanzieller Belastung, wird diese als „financial toxicity“ bezeichnet. PatientInnen, bei denen „financial toxicity“ auftritt, berichten von einer eingeschränkten Lebensqualität und können auch geringere Überlebensraten aufweisen. Deshalb ist es wichtig, dass die finanziellen Belastungen von KrebspatientInnen in Deutschland ernst genommen und entsprechende Gegenmaßnahmen initiiert werden.

Abstract

Despite universal health insurance and a well-established social security system in Germany, it is possible that cancer survivors will experience a financial burden. Objective financial burdens such as out-of-pocket payments and income losses can lead to subjective financial burden in cancer patients. Subjective financial burden can be observed at the material, psychosocial, and behavioral level. Survivors suffering from subjective financial burden are said to be affected by “financial toxicity”. Survivors experiencing financial toxicity report impairments in quality of life and may have lower survival rates. Therefore, it is crucial that the financial burden of cancer survivors in Germany be recognized and that actions to counter financial toxicity are implemented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. (Eortc) EOORaTOC Financial Toxicity.

  2. Altice CK, Banegas MP, Tucker-Seeley RD et al (2017) Financial hardships experienced by cancer survivors: a systematic review. J Natl Cancer Inst 109. https://doi.org/10.1093/jnci/djw205

  3. Arndt V, Koch-Gallenkamp L, Bertram H et al (2019) Return to work after cancer. A multi-regional population-based study from Germany. Acta Oncol 58:811–818

    Article  PubMed  Google Scholar 

  4. Baili P, Di Salvo F, De Lorenzo F et al (2016) Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis: an Italian population-based study. Support Care Cancer 24:2225–2233

    Article  PubMed  Google Scholar 

  5. Buttner M, Konig HH, Lobner M et al (2019) Out-of-pocket-payments and the financial burden of 502 cancer patients of working age in Germany: results from a longitudinal study. Support Care Cancer 27:2221–2228

    Article  PubMed  Google Scholar 

  6. Buttner M, Singer S, Hentschel L et al (2022) Financial toxicity in sarcoma patients and survivors in Germany: results from the multicenter PROSa study. Support Care Cancer 30:187–196

    Article  PubMed  Google Scholar 

  7. Carlson MA, Fradgley EA, Bridge P et al (2022) The dynamic relationship between cancer and employment-related financial toxicity: an in-depth qualitative study of 21 Australian cancer survivor experiences and preferences for support. Support Care Cancer 30:3093–3103

    Article  PubMed  Google Scholar 

  8. Carrera PM, Kantarjian HM, Blinder VS (2018) The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J Clin 68:153–165

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ernst J, Mehnert A, Weis J et al (2016) Social counseling in outpatient cancer counseling centers : Offers and use by advice-seekers. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 59:1476–1483

    Article  PubMed  Google Scholar 

  10. Fenn KM, Evans SB, Mccorkle R et al (2014) Impact of financial burden of cancer on survivors’ quality of life. J Oncol Pract 10:332–338

    Article  PubMed  Google Scholar 

  11. Hernandez D, Schlander M (2021) Income loss after a cancer diagnosis in Germany: an analysis based on the socio-economic panel survey. Cancer Med 10:3726–3740

    Article  PubMed  PubMed Central  Google Scholar 

  12. Iragorri N, De Oliveira C, Fitzgerald N et al (2021) The out-of-pocket cost burden of cancer care—A systematic literature review. Curr Oncol 28:1216–1248

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kale HP, Carroll NV (2016) Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer 122:283–289

    Article  PubMed  Google Scholar 

  14. Lueckmann SL, Schumann N, Hoffmann L et al (2020) ‘It was a big monetary cut’—A qualitative study on financial toxicity analysing patients’ experiences with cancer costs in Germany. Health Soc Care Community 28:771–780

    Article  PubMed  Google Scholar 

  15. Mcguire A, Drummond M, Martin M et al (2015) End of life or end of the road? Are rising cancer costs sustainable? Is it time to consider alternative incentive and funding schemes? Expert Rev Pharmacoecon Outcomes Res 15:599–605

    Article  PubMed  Google Scholar 

  16. Mehlis K, Witte J, Surmann B et al (2020) The patient-level effect of the cost of Cancer care—financial burden in German Cancer patients. BMC Cancer 20:529

    Article  PubMed  PubMed Central  Google Scholar 

  17. Mehnert A, De Boer A, Feuerstein M (2013) Employment challenges for cancer survivors. Cancer 119(Suppl 11):2151–2159

    Article  PubMed  Google Scholar 

  18. Mehnert A, Koch U (2013) Predictors of employment among cancer survivors after medical rehabilitation—a prospective study. Scand J Work Environ Health 39:76–87

    Article  PubMed  Google Scholar 

  19. Mols F, Tomalin B, Pearce A et al (2020) Financial toxicity and employment status in cancer survivors. A systematic literature review. Support Care Cancer 28:5693–5708

    Article  PubMed  PubMed Central  Google Scholar 

  20. Pearce A, Tomalin B, Kaambwa B et al (2019) Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivors. J Cancer Surviv 13:10–20

    Article  PubMed  Google Scholar 

  21. Ramsey SD, Bansal A, Fedorenko CR et al (2016) Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol 34:980–986

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Schneider J, Hernandez D, Group CS et al (2022) Out-of-pocket payments and loss of income among long-term breast cancer survivors in Germany: a multi-regional population-based study. J Cancer Surviv. https://doi.org/10.1007/s11764-022-01293-x

  23. Schroder SL, Schumann N, Fink A et al (2020) Coping mechanisms for financial toxicity: a qualitative study of cancer patients’ experiences in Germany. Support Care Cancer 28:1131–1139

    Article  PubMed  Google Scholar 

  24. Singer S, Roick J, Meixensberger J et al (2018) The effects of multi-disciplinary psycho-social care on socio-economic problems in cancer patients: a cluster-randomized trial. Support Care Cancer 26:1851–1859

    Article  PubMed  Google Scholar 

  25. Warner EL, Millar MM, Orleans B et al (2022) Cancer survivors’ financial hardship and their caregivers’ employment: results from a statewide survey. J Cancer Surviv. https://doi.org/10.1007/s11764-022-01203-1

  26. Witte J, Mehlis K, Surmann B et al (2019) Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications. Ann Oncol 30:1061–1070

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Medizinische Biometrie, Epidemiologie und Informatik (IMBEI), Rhabanusstr. 3, Bonifazius-Turm A, 55118, Mainz, Deutschland

    Matthias Büttner

Authors
  1. Matthias Büttner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthias Büttner.

Ethics declarations

Interessenkonflikt

M. Büttner hat Honorare für Vorträge, ohne Bezug zum Beitrag, bei Takeda und Lilly gehalten.

Für diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Büttner, M. Financial Toxicity. Forum 38, 210–214 (2023). https://doi.org/10.1007/s12312-023-01198-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12312-023-01198-5

Schlüsselwörter

Keywords

Search

Navigation